Emerging therapies and challenges in spinal muscular atrophy

Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity ranging from progressive infantile paralysis and premature death (type I) to limited motor neuron loss and normal life expectancy (type IV). Without disease‐modifying therapies, the impact is profound for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrar, Michelle A., Park, Susanna B., Vucic, Steve, Carey, Kate A., Turner, Bradley J., Gillingwater, Thomas H., Swoboda, Kathryn J., Kiernan, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396275/
https://www.ncbi.nlm.nih.gov/pubmed/28026041
http://dx.doi.org/10.1002/ana.24864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396275/
https://www.ncbi.nlm.nih.gov/pubmed/28026041
http://dx.doi.org/10.1002/ana.24864

Ejemplares similares